Soluble Urokinase Plasminogen Activator Receptor (SuPAR) as a Therapeutic Target for Prevention and Treatment of Atherosclerosis
TECHNOLOGY NUMBER: 2021-428
Phosphatidylinositide 3-kinase Inhibitor Combined with Alpha-PD-1 Achieve Complete Remission in Metastatic Cancer
TECHNOLOGY NUMBER: 2021-366
Bile Salt and Corticosteroid Microparticles for Controlled Release Drug Delivery Applications
TECHNOLOGY NUMBER: 2021-314
Pharmacologic Activation of Autophagy without Direct mTOR Inhibition; a Therapeutic Strategy to Treat Dry Macular Degeneration
TECHNOLOGY NUMBER: 2020-502
Biodegradable protein based Nanoparticles for drug delivery
TECHNOLOGY NUMBER: 2020-143
High Density Electrophysiological Predicts Span of Therapeutic Tissue Activation Volumes in Subthalamic Deep Brain Stimulation …
TECHNOLOGY NUMBER: 2019-221
Chimeric Antigen Receptor Comprising CD123 Binding Domain and IL-7 Intracellular Signaling Domain for combination T Cell Therapy
TECHNOLOGY NUMBER: 2018-238
Hydrogel Guidance Tubes for Aligned Tissue Regeneration
TECHNOLOGY NUMBER: 7763
Use of 4-PBA for the Prevention and Treatment of Vascular Lesions in CM-AVM
TECHNOLOGY NUMBER: 2020-058
Tofacitinib for Treatment of Amyotrophic Lateral Sclerosis
TECHNOLOGY NUMBER: 2019-053
Use of Retinoids in Congenital Erythropoietic Porphyria
TECHNOLOGY NUMBER: 2022-276
Therapeutic Use of Carbamoyl Phosphate Synthatase-1
TECHNOLOGY NUMBER: 2019-076
Methods for the Treatment of Nicotine Dependence
TECHNOLOGY NUMBER: 2020-397
Pharmacotherapies for COVID-19
TECHNOLOGY NUMBER: 2020-487
Lactoferrin Inhibition of SARS-CoV-2 Viral Entry and Immunomodulatory Suppression of IL-6
TECHNOLOGY NUMBER: 2020-433
Selective Kinase Degraders (PROTACs) for Oncology
TECHNOLOGY NUMBER: 2022-262
Meta Anilide Inhibitors of MRTF
TECHNOLOGY NUMBER: 2021-316
HDAC6 Inhibitors to Treat Diabetes
TECHNOLOGY NUMBER: 2021-217
Composition for Monomer Ash1L Inhibitors and Method of Use Thereof
TECHNOLOGY NUMBER: 2019-153
High-Throughput Screening Method for Identifying Monoclonal Antibodies with Drug-Like Colloidal and Viscoelastic Properties
TECHNOLOGY NUMBER: 2019-346
Graves Eye Disease New Treatment
TECHNOLOGY NUMBER: 2018-321
Polygenic Markers of Hepatic Steatosis and Cirrhosis
TECHNOLOGY NUMBER: 2021-461
Modulating the Gut Microbiome to Treat Disease
TECHNOLOGY NUMBER: 2022-186
PRC1 Inhibitors
TECHNOLOGY NUMBER: 2018-372
Novel Small Molecules and Their Use as MALT1 Inhibitors
TECHNOLOGY NUMBER: 2021-126
Novel Structure-Based Rifamycins for Drug-Resistant TB and HIV Co-Infection
TECHNOLOGY NUMBER: 2021-114
ML355-sHDL as a New Delivery Mechanism for Antiplatelet Therapy Targeting 12-Lipoxygenase
TECHNOLOGY NUMBER: 2021-132
The Method to Give Bacteria Probiotic Features by Genetic Engineering
TECHNOLOGY NUMBER: 2021-103
Carbon Nanotubules for Delivery of the Ocular Drugs
TECHNOLOGY NUMBER: 2019-427
Photomediated Ultrasound Therapy Method and Apparatus
TECHNOLOGY NUMBER: 7785
GRP78 Inhibitors and Degraders for the Treatment of Cancer, Viral Infection, and Inflammatory Diseases
TECHNOLOGY NUMBER: 2021-276
2-Hydroxybenzoic Acid Derivatives as Inhibitors and Degraders of Sirtuins
TECHNOLOGY NUMBER: 2022-340
Modulation of Pyruvate Kinase M2 as a Therapeutic Strategy for Proliferative Vitreoretinopathy
TECHNOLOGY NUMBER: 2022-202
BanLec-CAR T Cells for Cancer Therapy
TECHNOLOGY NUMBER: 2019-123
Compositions and Methods for Treating Adrenocortical Carcinoma and Excess Steroid Production
TECHNOLOGY NUMBER: 7401
Small-Molecule Inhibitors of DCN1
TECHNOLOGY NUMBER: 7301
Covalent Small-Molecule Inhibitors of DCN1 Protein
TECHNOLOGY NUMBER: 7456
ARlnc1 in Prostate Cancer Progression
TECHNOLOGY NUMBER: 7386
Lipids for Nucleic Acid Based Vaccines
TECHNOLOGY NUMBER: 2022-117
Dual-Function Lipidated NCEs
TECHNOLOGY NUMBER: 2022-116
Chlorophenyl Inhibitors of Glucosylceramide Synthase
TECHNOLOGY NUMBER: 2019-311
Pyridine Inhibitors of Glucosylceramide Synthase
TECHNOLOGY NUMBER: 2019-268
Synthetic High Density Lipoprotein for Treatment of Infections Complications
TECHNOLOGY NUMBER: 2020-434
A Small Molecular Compound for Arthritis and Bone Erosion Treatment
TECHNOLOGY NUMBER: 7656
New Oral Drug Strategy for Targeting Pancreas
TECHNOLOGY NUMBER: 2021-411
Gastrointestinal (GI) Locally-Activating JAK Inhibitor for Treatment of Ulcerative Colitis
TECHNOLOGY NUMBER: 2022-281
Targeting Oncogenic Transcriptional Programs Through Tissue Specificity
TECHNOLOGY NUMBER: 2021-208
Nanoemulsion Vaccine Induces Cross-Protection to Suppress Reactivity to Multiple Food Allergens
TECHNOLOGY NUMBER: 2021-194
BpV(pic) and Hair Growth
TECHNOLOGY NUMBER: 2021-308
IgA Induced Mucosal Immune Tolerance
TECHNOLOGY NUMBER: 2021-134
Novel Drug Formulation
TECHNOLOGY NUMBER: 2019-436
Role of Nanoemulsion Vaccine in Chronic Cockroach Allergic Asthma
TECHNOLOGY NUMBER: 2019-481
Sting Agonist, Nanoformulations, and their uses For Treatment of Cancer, Viral Infection, and Bacterial Infection
TECHNOLOGY NUMBER: 2022-078
SGLT Inhibitor Drug for Treating Liver Diseases
TECHNOLOGY NUMBER: 2021-312
Combined Agonist Adjuvants for Vaccines
TECHNOLOGY NUMBE: 2021-322
Microbial Metabolites for Improving Cancer Immunotherapy
TECHNOLOGY NUMBER: 2021-483
Small Molecule Activation of Lysosomal TRP Channels Ameliorates Duchenne Muscular Dystrophy in Mouse Models
TECHNOLOGY NUMBER: 2019-270
PKC Inhibition to Allow Extended tPA Treatment for Stroke
TECHNOLOGY NUMBER: 7702
Updated Non-Invasive Cervical Cerclage
TECHNOLOGY NUMBER: 2021-392
Cancer Stem Cell Vaccination and Treatment
TECHNOLOGY NUMBER: 5486
Phase Correction for Single Pixel Camera in a Lissajous Pattern
TECHNOLOGY NUMBER: 2018-422
A Concentrated Form of Valproate to be Delivered via Bone for the Treatment of Hemorrhagic Shock
TECHNOLOGY NUMBER: 2019-471
Development of a Therapeutic Against Flavivirus NS1 Protein as a Treatment for Flavivirus Infection
TECHNOLOGY NUMBER: 2020-429
Novel Particles as an Acute Lung Injury Therapeutic via Rapid Blocking of Neutrophil Migration in the Lungs
TECHNOLOGY NUMBER: 2019-409
Development of Novel Pyruvate Kinase Muscle Isoform 2 (PKM2) Activators for Photoreceptor Neuroprotection
TECHNOLOGY NUMBER: 2020-183
Mitochondrial Targeting Compounds for the Treatment of Associated Diseases
TECHNOLOGY NUMBER: 2020-134
Methods for Establishing Drug Supersaturation from a Porous Host
TECHNOLOGY NUMBER: 2019-069
Ear Implant for Reconstruction
TECHNOLOGY NUMBER: 7095